Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
| Title : Dutogliptin, a selective DPP4 inhibitor, improves glycaemic control in patients with type 2 diabetes: a 12-week, double-blind, randomized, placebo-controlled, multicentre trial - Pattzi_2010_Diabetes.Obes.Metab_12_348 |
| Author(s) : Pattzi HM , Pitale S , Alpizar M , Bennett C , O'Farrell AM , Li J , Cherrington JM , Guler HP |
| Ref : Diabetes Obes Metab , 12 :348 , 2010 |
| Abstract : Pattzi_2010_Diabetes.Obes.Metab_12_348 |
| ESTHER : Pattzi_2010_Diabetes.Obes.Metab_12_348 |
| PubMedSearch : Pattzi_2010_Diabetes.Obes.Metab_12_348 |
| PubMedID: 20380656 |
| Title : The dipeptidyl peptidase-4 inhibitor PHX1149 improves blood glucose control in patients with type 2 diabetes mellitus - Garcia-Soria_2008_Diabetes.Obes.Metab_10_293 |
| Author(s) : Garcia-Soria G , Gonzalez-Galvez G , Argoud GM , Gerstman M , Littlejohn TW, 3rd , Schwartz SL , O'Farrell AM , Li X , Cherrington JM , Bennett C , Guler HP |
| Ref : Diabetes Obes Metab , 10 :293 , 2008 |
| Abstract : Garcia-Soria_2008_Diabetes.Obes.Metab_10_293 |
| ESTHER : Garcia-Soria_2008_Diabetes.Obes.Metab_10_293 |
| PubMedSearch : Garcia-Soria_2008_Diabetes.Obes.Metab_10_293 |
| PubMedID: 18333888 |
| Title : Pharmacokinetic and pharmacodynamic assessments of the dipeptidyl peptidase-4 inhibitor PHX1149: double-blind, placebo-controlled, single- and multiple-dose studies in healthy subjects - O'Farrell_2007_Clin.Ther_29_1692 |
| Author(s) : O'Farrell AM , van Vliet A , Abou Farha K , Cherrington JM , Campbell DA , Li X , Hanway D , Li J , Guler HP |
| Ref : Clin Ther , 29 :1692 , 2007 |
| Abstract : O'Farrell_2007_Clin.Ther_29_1692 |
| ESTHER : O'Farrell_2007_Clin.Ther_29_1692 |
| PubMedSearch : O'Farrell_2007_Clin.Ther_29_1692 |
| PubMedID: 17919550 |